GLAD, SAD, BAD, and MAD Policies and Programs: A Call to Evaluate Efficiency in Pharmaceutical Systems

Abstract

The pharmaceutical landscape is a complex mix of innovation, regulation, and market forces. As healthcare systems face rising costs and increasing demand for effective treatments, it is essential to evaluate the efficiency of policies and programs that determine access to and affordability of medications. This editorial introduces a framework of GLAD, SAD, BAD, and MAD policies and programs to categorize the efficiency and economic viability of pharmaceutical interventions. By critically assessing these categories, we aim to highlight the need for a systematic review of current practices and encourage a shift toward more sustainable healthcare solutions.